GURUFOCUS.COM » STOCK LIST » Industrials » Business Services » Jinhai Medical Technology Ltd (HKSE:02225) » Definitions » EV-to-EBIT

Jinhai Medical Technology (HKSE:02225) EV-to-EBIT : -349.38 (As of Jun. 25, 2024)


View and export this data going back to 2017. Start your Free Trial

What is Jinhai Medical Technology EV-to-EBIT?

EV-to-EBIT is calculated as Enterprise Value divided by its EBIT. As of today, Jinhai Medical Technology's Enterprise Value is HK$6,146.7 Mil. Jinhai Medical Technology's EBIT for the trailing twelve months (TTM) ended in Dec. 2023 was HK$-17.6 Mil. Therefore, Jinhai Medical Technology's EV-to-EBIT for today is -349.38.

The historical rank and industry rank for Jinhai Medical Technology's EV-to-EBIT or its related term are showing as below:

HKSE:02225' s EV-to-EBIT Range Over the Past 10 Years
Min: -368.25   Med: 303.52   Max: 8355.79
Current: -349.38

During the past 10 years, the highest EV-to-EBIT of Jinhai Medical Technology was 8355.79. The lowest was -368.25. And the median was 303.52.

HKSE:02225's EV-to-EBIT is ranked worse than
100% of 852 companies
in the Business Services industry
Industry Median: 12.25 vs HKSE:02225: -349.38

Joel Greenblatt calls the inversion of this ratio Earnings Yield (Joel Greenblatt) %. Jinhai Medical Technology's Enterprise Value for the quarter that ended in Dec. 2023 was HK$2,978.5 Mil. Jinhai Medical Technology's EBIT for the trailing twelve months (TTM) ended in Dec. 2023 was HK$-17.6 Mil. Jinhai Medical Technology's Earnings Yield (Joel Greenblatt) % for the quarter that ended in Dec. 2023 was -0.59%.


Jinhai Medical Technology EV-to-EBIT Historical Data

The historical data trend for Jinhai Medical Technology's EV-to-EBIT can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Jinhai Medical Technology EV-to-EBIT Chart

Jinhai Medical Technology Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
EV-to-EBIT
Get a 7-Day Free Trial Premium Member Only Premium Member Only 712.03 155.19 8,355.79 513.57 -169.57

Jinhai Medical Technology Semi-Annual Data
Dec14 Dec15 Dec16 Jun17 Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23
EV-to-EBIT Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 8,355.79 - 513.57 - -169.57

Competitive Comparison of Jinhai Medical Technology's EV-to-EBIT

For the Staffing & Employment Services subindustry, Jinhai Medical Technology's EV-to-EBIT, along with its competitors' market caps and EV-to-EBIT data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Jinhai Medical Technology's EV-to-EBIT Distribution in the Business Services Industry

For the Business Services industry and Industrials sector, Jinhai Medical Technology's EV-to-EBIT distribution charts can be found below:

* The bar in red indicates where Jinhai Medical Technology's EV-to-EBIT falls into.



Jinhai Medical Technology EV-to-EBIT Calculation

Jinhai Medical Technology's EV-to-EBIT for today is calculated as:

EV-to-EBIT=Enterprise Value (Today)/EBIT (TTM)
=6146.707/-17.593
=-349.38

Jinhai Medical Technology's current Enterprise Value is HK$6,146.7 Mil.
For company reported semi-annually, GuruFocus uses latest annual data as the TTM data. Jinhai Medical Technology's EBIT for the trailing twelve months (TTM) ended in Dec. 2023 was HK$-17.6 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Jinhai Medical Technology  (HKSE:02225) EV-to-EBIT Explanation

This is a more accurate valuation of companies' operation because it considers the debt and cash on its balance sheet, and non-operating items such as interest payment, tax, and one-time items are not included in the Operating Income.

Joel Greenblatt calls the inversion of this ratio Earnings Yield (Joel Greenblatt) %.

Jinhai Medical Technology's Earnings Yield (Joel Greenblatt) % for the quarter that ended in Dec. 2023 is calculated as:

Earnings Yield (Joel Greenblatt) % (Q: Dec. 2023 ) =EBIT / Enterprise Value (Q: Dec. 2023 )
=-17.593/2978.458
=-0.59 %

Jinhai Medical Technology's Enterprise Value for the quarter that ended in Dec. 2023 was HK$2,978.5 Mil.
For company reported semi-annually, GuruFocus uses latest annual data as the TTM data. Jinhai Medical Technology's EBIT for the trailing twelve months (TTM) ended in Dec. 2023 was HK$-17.6 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Jinhai Medical Technology EV-to-EBIT Related Terms

Thank you for viewing the detailed overview of Jinhai Medical Technology's EV-to-EBIT provided by GuruFocus.com. Please click on the following links to see related term pages.


Jinhai Medical Technology (HKSE:02225) Business Description

Traded in Other Exchanges
N/A
Address
31 Sungei Kadut Avenue, Singapore, SGP, 729660
Jinhai International Group Holdings Ltd is a Singapore-based company engaged in the provision of manpower outsourcing and ancillary services to building and construction contractors in Singapore. It also provides dormitory services, IT services, and construction ancillary services including warehousing services, cleaning services, and building maintenance work in Singapore. It earns a vast majority of its revenues from the Manpower outsourcing and ancillary services segment.
Executives
Liu Lei 2101 Beneficial owner
Chen Guobao 2201 Interest of corporation controlled by you
Full Fortune International Co., Ltd. 2101 Beneficial owner
Jiang Xiahong 2202 Interest of your spouse

Jinhai Medical Technology (HKSE:02225) Headlines

No Headlines